Rik Hermanides

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial

Marieke E. Gimbel, Khalid Qaderdan, Laura M. Willemsen et al. · The Lancet · 2020 · 342 citations · Full text

Thrombosis, Popular Age, Cardiovascular Disease +9

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 142 citations · Full text

Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries

Marijke Linschoten, Alicia Uijl, Astrid Schut et al. · European Heart Journal · 2021 · 55 citations · Full text

Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus

Mark Kennedy, E. Kaplan, Rik Hermanides et al. · Cardiovascular Diabetology · 2016 · 43 citations · Full text

Fractional Flow Reserve–Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus

Mark Kennedy, Rik Hermanides, E. Kaplan et al. · The American Journal of Cardiology · 2016 · 21 citations · Full text

Diabetes Management, Ophthalmology, Fractional Flow +6